NCT00509639View on ClinicalTrials.gov

Evaluation of Topical 10% Metronidazole Ointment for the Treatment of Active Perianal Crohn's Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Crohn's Disease
Interventions
DRUG

10% Metronidazole Ointment

Metronidazole 10% ointment applied perianally three times daily for four weeks. Placebo ointment applied perianally three times daily for four weeks

Trial Locations (11)

M 63110

Washington University School of Medicine, St Louis

DE22 3NE

Derby City General Hospital, Derby

LE5 4PW

Leicester General Hospital, Leicester

ML6 0JS

Monklands Hospital, Airdrie

B9 5SS

Birmingham Heartlands Hospital, Birmingham

BS1 3NU

Bristol Royal Infirmary, Bristol

CF14 4XW

University Hospital of Wales, Cardiff

CV2 2DX

University Hospital of Warwick and Coventry, Coventry

HA1 3UJ

St Marks Hospital, Harrow

SE1 &EH

St Thomas Hospital, London

PE3 6DA

Peterborough District Hospital, Peterborough

All Listed Sponsors
lead

S.L.A. Pharma AG

INDUSTRY

NCT00509639 - Evaluation of Topical 10% Metronidazole Ointment for the Treatment of Active Perianal Crohn's Disease | Biotech Hunter | Biotech Hunter